DiethylaminoethanolSee also what's at your library, or elsewhere.
Broader terms:Narrower term:Used for:- Beta-diethylaminoethyl alcohol
- DEAE (Chemical)
- Diethylethanolamine
- Hydroxytriethylamine
|
Filed under: Diethylaminoethanol
Filed under: Diethylaminoethanol -- California -- Riverside
Items below (if any) are from related and broader terms.
Filed under: LSD (Drug) LSD-25: a factual account; layman's guide to the pharmacology, physiology, psychology, and sociology of LSD (U.S. Bureau of Narcotics and Dangerous Drugs; [for sale by the Supt. of Docs., U.S. Govt. Print. Off.], 1970), by Louise G. Richards and United States. Bureau of Narcotics and Dangerous Drugs (page images at HathiTrust; US access only) Questions and answers : LSD. (Michigan Dept. of Education, 1968), by Michigan. Department of Education (page images at HathiTrust; US access only) Narcotics and dangerous drugs : San Diego November 13, 14, and 15, 1963 (The Committee, 1963), by California. Legislature. Assembly. Committee on Criminal Procedure (page images at HathiTrust; US access only) Short-term effects of LSD on anxiety, attitudes, and performance [by] William H. McGlothlin [et al.] (Santa Monica, Calif., 1963), by William H McGlothlin (page images at HathiTrust; US access only) LSD in the United States. (Drug Enforcement Administration, Strategic Intelligence Section, Domestic Unit, 1995), by United States. Drug Enforcement Administration (page images at HathiTrust) LSD : the age of mind (Fulton's Offset Press ;, 1963), by Bernard Roseman, Julio Mario Santo Domingo Collection, and Fitz Hugh Ludlow Memorial Library (page images at HathiTrust; US access only) Catalogue of the literature on Delysid-D-lysergic acid diethylamide or LSD 25. (Hanover, N.J. : [publisher not identified], [1958?], 1958), by Sandoz Pharmaceuticals (page images at HathiTrust; US access only)
Filed under: LSD (Drug) -- AdministrationFiled under: LSD (Drug) -- BibliographyFiled under: LSD (Drug) -- Congresses Adverse reactions to hallucinogenic drugs, with background papers; conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967. (U.S. National Institute of Mental Health; [for sale by Supt. of Docs., U.S. Govt. Print. Off., Washington, 1969), by Roger E. Meyer, National Clearinghouse for Mental Health Information (U.S.), and National Institute of Mental Health (U.S.). Center for Studies of Narcotic and Drug Abuse (page images at HathiTrust) Filed under: LSD (Drug) -- MichiganFiled under: LSD (Drug) -- Physiological effectFiled under: LSD (Drug) -- ResearchFiled under: LSD (Drug) -- TestingFiled under: LSD (Drug) -- Toxicology
Filed under: Ethanolamines Performance of a Girbotol purification plant at Louisiana, Mo. (Dept. of the Interior, Bureau of Mines, 1956), by L. L. Hirst, L. P. Wenzell, H. R. Batchelder, L. F. Willmott, and United States Bureau of Mines (page images at HathiTrust) Über vollständig hydrierte Fette. Über Phenyl-1-äthanol-1-amin-2 und verwandte Verbindungen. (Huth, 1914), by Ernst Thiele (page images at HathiTrust; US access only) Über vollständig hydrierte Fette. Über Phenyl-1-äthanol-1-amin-2 und verwandte Verbindungen. (Huth, 1914), by Ernst Thiele (page images at HathiTrust; US access only)
Filed under: Norepinephrine Neural Control of Renal Function (San Rafael, CA: Morgan and Claypool Life Sciences, 2011), by Ulla Kopp (illustrated HTML at NIH) Chemical quantitation of epinephrine and norepinephrine in plasma. (Thomas, 1959), by William Muir Manger (page images at HathiTrust) Adrenergic mechanisms affecting circulatory dynamics in hypothermia (Wright-Patterson Air Force Base, Ohio : Aerospace Medical Research Laboratories, Aerospace Medical Division, Air Force Systems Command, United States Air Force, 1968., 1968), by E. T. Angelakos, Joan B. Daniels, Aerospace Medical Research Laboratories (U.S.), and Boston University. School of Medicine (page images at HathiTrust)
Filed under: Gaucher disease Gaucher disease ([The Institutes], 1995), by Md.) National Institutes of Health Technology Assessment Conference (1995 : Bethesda, National Institute of Child Health and Human Development (U.S.), National Institutes of Health (U.S.). Office of Medical Applications of Research, and National Institute of Mental Health (U.S.) (page images at HathiTrust) Understanding Gaucher Disease (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Clinical Center, 1990), by Carol Kari, Wendy Schubert, and National Institutes of Health (U.S.). Office of Clinical Center Communications (page images at HathiTrust)
Filed under: Gaucher disease -- BibliographyFiled under: Gaucher disease -- Congresses Gaucher disease ([The Institutes], 1995), by Md.) National Institutes of Health Technology Assessment Conference (1995 : Bethesda, National Institute of Child Health and Human Development (U.S.), National Institutes of Health (U.S.). Office of Medical Applications of Research, and National Institute of Mental Health (U.S.) (page images at HathiTrust) Filed under: Gaucher disease -- Genetic aspects
Filed under: Gaucher disease -- Treatment -- United States Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton) Understanding Gaucher Disease (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Clinical Center, 1990), by Carol Kari, Wendy Schubert, and National Institutes of Health (U.S.). Office of Clinical Center Communications (page images at HathiTrust) Filed under: Gaucher disease -- United StatesFiled under: Cerebrin |